← Stock Trading Canary · All insider profiles
INSIDER PROFILE · DE
Wilhelm Beier
Supervisory Board Member (Aufsichtsrat) · Initial notification
Profile key: de|wilhelm beier
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 8
- Average purchase
- —
- Gross purchase value
- —
- Last purchase
- 2026-05-14
- Completed 20D events
- 8.0
- Outcome status
- PASS
Latest company: Dermapharm Holding SE
Companies: Dermapharm Holding SE
Post-purchase outcomes
Benchmark-relative outcomes are available against DAX.
- Excess return = stock return − DAX return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 8Developing | 100.0% (8/8) | 37.5% (3/8) | -1.8% | -1.3% | -8.5% |
| 20D | 8Developing | 100.0% (8/8) | 37.5% (3/8) | -4.5% | -2.1% | -8.9% |
| 60D | 8Developing | 100.0% (8/8) | 25.0% (2/8) | -11.2% | -10.2% | -30.2% |
| 120D | 7Developing | 100.0% (7/7) | 42.9% (3/7) | -10.5% | -4.1% | -30.1% |
Research patterns
- First purchase in 12M
- 0/8
- Large purchase ≥ €100k
- 4/4
- Cluster buying · 15D
- 2/8
- Buying the dip · ≥20% below prior 52W high
- 0/8
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.